McDonald’s Shares Fall as Weight-Loss Drugs Threaten Earnings
McDonald’s shares dropped 1.7% on Tuesday after a downgrade by equity analysis firm Redburn Atlantic, citing the growing popularity of weight-loss drugs that regulate blood sugar and appetite. The class of drugs known as GLP-1s is expected to transform Americans’ food consumption habits, posing a threat to fast-food chains catering to lower-income consumers. According to … Read more